Multiple-dose Proportionality Assessment

Multiple-Dose Proportionality Assessment is a pharmacokinetic evaluation method used to determine whether steady-state drug exposure increases in direct proportion to the administered dose across multiple dosing regimens, distinguishing it from single-dose assessments by focusing on cumulative exposure and time-dependent changes in drug disposition.

1

Publications

20

Citations

5

Authors

4

Institutions

Publications per year

2017–2026

0

Authors

5

  1. SA
    Silke Appel‐Dingemanse

    Novartis (Switzerland), Switzerland

    1 publications · 20 citations

    1

    h-index

  2. FP
    F. Pommier

    Novartis (Switzerland), Switzerland

    1 publications · 20 citations

    1

    h-index

  3. JF
    James F. McLeod

    Novartis (Switzerland), Switzerland

    1 publications · 20 citations

    1

    h-index

  4. SO
    Stuart Osborne

    Roche (Switzerland), Switzerland

    1 publications · 20 citations

    1

    h-index

  5. YH
    Yulia Hirschberg

    Deaconess Hospital, United States

    1 publications · 20 citations

    1

    h-index

1–5 of 5

Venues

  1. European Journal of Clinical Pharmacology

    1 publications · 20 citations

    1

    h-index

1–1